MEDIFAST INC (MED)vsPDD Holdings Inc. (PDD)
MED
MEDIFAST INC
$10.87
-0.46%
CONSUMER CYCLICAL · Cap: $118.70M
PDD
PDD Holdings Inc.
$98.03
+0.27%
CONSUMER CYCLICAL · Cap: $139.17B
Smart Verdict
WallStSmart Research — data-driven comparison
PDD Holdings Inc. generates 111839% more annual revenue ($431.85B vs $385.79M). PDD leads profitability with a 23.0% profit margin vs -4.8%. PDD appears more attractively valued with a PEG of 0.70. PDD earns a higher WallStSmart Score of 75/100 (B+).
MED
Hold45
out of 100
Grade: D
PDD
Strong Buy75
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for MED.
Margin of Safety
+78.1%
Fair Value
$488.79
Current Price
$98.03
$390.76 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Generating 24.1B in free cash flow
Large-cap with strong market position
Every $100 of equity generates 27 in profit
Keeps 23 of every $100 in revenue as profit
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -9.1% — below average capital efficiency
Revenue declined 36.9%
Weak financial health signals
Earnings declined 10.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : MED
The strongest argument for MED centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bull Case : PDD
The strongest argument for PDD centers on P/E Ratio, Debt/Equity, Free Cash Flow. Profitability is solid with margins at 23.0% and operating margin at 22.4%. Revenue growth of 12.0% demonstrates continued momentum.
Bear Case : MED
The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : PDD
The primary concerns for PDD are Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
MED profiles as a turnaround stock while PDD is a mature play — different risk/reward profiles.
MED carries more volatility with a beta of 0.56 — expect wider price swings.
PDD is growing revenue faster at 12.0% — sustainability is the question.
PDD generates stronger free cash flow (24.1B), providing more financial flexibility.
Bottom Line
PDD scores higher overall (75/100 vs 45/100), backed by strong 23.0% margins and 12.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MEDIFAST INC
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Visit Website →PDD Holdings Inc.
CONSUMER CYCLICAL · INTERNET RETAIL · China
Pinduoduo Inc., operates an electronic commerce platform in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.
Visit Website →Compare with Other PERSONAL SERVICES Stocks
Want to dig deeper into these stocks?